Buscar resultados de ensayos clínicos
Neisseria Meningitidis Infection - 19 Studies Found
| Estado | Estudiar |
| Completed |
Nombre del estudio: Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of a Booster Dose of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received Three Doses of the Same Vaccine Condición: Meningococcal Disease Fecha: 2009-12-04 Intervenciones:
|
| Completed |
Nombre del estudio: A Phase 3b, Single-Center, Open-label Study to Assess the Immunogenicity and Safety of Novartis Meningococcal B Recombinant Vaccine When Administered at a 0, 2-Month Schedule in Healthy At-Risk Adults Aged 18 to 65 Years Inclusive. Condición: Prevention of the Meningococcal Disease Fecha: 2013-07-26 Intervenciones: Biological: rMenB+OMV NZ Recombinant MenB with Outer Member Vesicle (OMV) from the New Zealand strain |
| Completed |
Nombre del estudio: South Australian Meningococcal B Vaccine Herd Immunity Study Condición: Meningococcal Disease Fecha: 2017-03-17 Intervenciones: Biological: Licensed 4CMenB vaccine Two doses (0.5 mL each) of Bexsero ® vaccine at least 1 month t |
| Completed |
Nombre del estudio: PRIME Follow up - Quadri Meningo Vacinees Condición: Meningococcal Disease Fecha: 2016-06-15 Intervenciones: Other: venepuncture only single venepuncture |
| Active, not recruiting |
Nombre del estudio: Safety and Immunogenicity of an Aluminium Hydroxide/LHD153R Adjuvanted Meningococcal C-CRM197 Conjugate Vaccine Condición: Meningococcal Disease Fecha: 2015-12-21 Intervenciones:
|
| Completed |
Nombre del estudio: A Study to Evaluate 4-year Antibody Persistence and Booster Response Following MenABCWY Vaccination in Healthy Adolescents and Young Adults Who Previously Participated in Studies V102_02 (NCT01210885) and V102_02E1 (NCT01367158) Condición: Meningococcal Disease Fecha: 2015-05-04 Intervenciones: Biological: MenABCWY+OMV vaccine Intramuscular injection of a single dose at Day 1 to subjects in the Me |
| Active, not recruiting |
Nombre del estudio: Evaluation of Antibody Persistence Following 4 MenACWY Vaccinations Condición: Meningococcal Disease Fecha: 2015-05-13 Intervenciones: Biological: Menveo® Four Intramuscular doses of MenACWY vaccine at 2, 4, 6 and 12 months of age fol |
| Active, not recruiting |
Nombre del estudio: Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Infant Study Condición: Meningococcal Disease Fecha: 2014-10-27 Intervenciones: Biological: Meningococcal quadrivalent CRM-197 conjugate vaccine This study is strictly observational. D |
| Completed |
Nombre del estudio: Assessing the Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents Condición: Meningococcal Disease Fecha: 2014-11-05 Intervenciones:
|